Brief: CSL Ltd Sees High Single-Digit NPAT Growth Beyond FY26
05/11/2025 08:27
Nov 5 (Reuters) - CSL Ltd CSL.AX: SEES MID SINGLE-DIGIT REVENUE GROWTH BEYOND FY26 SEES HIGH SINGLE-DIGIT NPAT GROWTH BEYOND FY26 SEES CONTINUED DIVIDENDS AND MULTI-YEAR, ON-MARKET SHARE BUYBACKS BEYOND FY26 Further company coverage: CSL.AX ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Csl
See all newsEU Commission opens antitrust probe into Sanofi's flu vaccine campaign (updated)
EU Commission opens antitrust probe into Sanofi's flu vaccine campaign
Analysis: US prices for new drugs fell in 2025 as fewer costly gene therapies were launched
US military requires flu vaccine for some after outbreak in Texas training center
Corrected: BUZZ-Australian healthcare stocks hit a six-week high, acting as a primary hedge on ASX